reproterol

Small moleculeexperimental

Clinical trial activity

1 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2007 (NCT00777348)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

Cn1c(=O)c2c(ncn2CCCNCC(O)c2cc(O)cc(O)c2)n(C)c1=O
Mol. weight
389.41 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bronchodil
  • bronchodil
  • bronchospasmin
  • d-1959.hcl
  • d-1959.hcl
  • epiferol
  • epiferol
  • reproterol
  • reproterol
  • reproterol
  • reproterol
  • reproterol
  • reproterol
  • reproterol
  • reproterol hcl
  • reproterol hcl
  • reproterol hcl
  • reproterol hydrochloride
  • reproterol hydrochloride
  • reproterol hydrochloride
  • reproterol, (-)-isomer
  • reproterol monohydrochloride
  • reproterol monohydrochloride
  • w-2946m
  • w-2946m

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00777348Phase 2Nov 1, 2007ClinResearch, GmbH, Johannes Gutenburg University, Meda, Sanofi
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ClinResearch, GmbHFor profit1012007
Johannes Gutenburg UniversityAcademic/Hospital1012007
MedaFor profit1112007
SanofiFor profit1012007
4 organizations
Page 1 / 1